Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Braun

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Nature Microbiology|January 10, 2018
Dynamics of metatranscription in the inflammatory bowel disease gut microbiomeMelanie Schirmer, Eric A Franzosa, Jason Lloyd-Price, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Novel TechnologiesManish Dhyani, Nitin Joshi, Willem A Bemelman, et al.
Science (New York, N.Y.)|October 23, 2020
Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiotaKirk Bergstrom, Xindi Shan, David Casero, et al.
The Journal of Clinical Investigation|November 3, 2020
Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitinesSarah A Smith, Sayaka A Ogawa, Lillian Chau, et al.
Science (New York, N.Y.)|March 12, 2021
<i>Debaryomyces</i> is enriched in Crohn's disease intestinal tissue and impairs healing in miceUmang Jain, Aaron M Ver Heul, Shanshan Xiong, et al.
Human Pathology|May 11, 2007
A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics NetworkThomas A Drake, Jonathan Braun, Alberto Marchevsky, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
Molecular Cancer Therapeutics|May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer CellsChristen Dillard, Meagan Kiyohara, Vei Mah, et al.
Inflammatory Bowel Diseases|April 9, 2022
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF TherapyDalin Li, Alexander Xu, Emebet Mengesha, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Nature Microbiology|January 10, 2018
Dynamics of metatranscription in the inflammatory bowel disease gut microbiomeMelanie Schirmer, Eric A Franzosa, Jason Lloyd-Price, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Novel TechnologiesManish Dhyani, Nitin Joshi, Willem A Bemelman, et al.
Science (New York, N.Y.)|October 23, 2020
Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiotaKirk Bergstrom, Xindi Shan, David Casero, et al.
The Journal of Clinical Investigation|November 3, 2020
Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitinesSarah A Smith, Sayaka A Ogawa, Lillian Chau, et al.
Science (New York, N.Y.)|March 12, 2021
<i>Debaryomyces</i> is enriched in Crohn's disease intestinal tissue and impairs healing in miceUmang Jain, Aaron M Ver Heul, Shanshan Xiong, et al.
Human Pathology|May 11, 2007
A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics NetworkThomas A Drake, Jonathan Braun, Alberto Marchevsky, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
Molecular Cancer Therapeutics|May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer CellsChristen Dillard, Meagan Kiyohara, Vei Mah, et al.
Inflammatory Bowel Diseases|April 9, 2022
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF TherapyDalin Li, Alexander Xu, Emebet Mengesha, et al.
Pageof 19